Loomis Sayles’ Biggest Investments: Bank of America, Intel and Oracle

Wall St. Watchdog reveals information regarding Loomis Sayles’ top holdings for the quarter ending September 30th, 2011. The firm held 643 stocks at the end of the quarter with an aggregate market value of $15.615 billion.

  • Bank Of America Corporation (NYSE:BAC): On 06/30/2011 reported holding 1,388,660 shares with a market value of $1,392,478,815. This comprised 7.91% of the total portfolio. On 09/30/2011 reported holding 1,428,660 shares with a market value of $1,092,924,900. This comprised 7% of the total portfolio. The net change in shares for this position over the two quarters is 40,000.
  • Intel Corporation (NASDAQ:INTC): On 06/30/2011 reported holding 31,924,871 shares with a market value of $707,455,136. This comprised 4.02% of the total portfolio. On 09/30/2011 reported holding 31,994,985 shares with a market value of $682,772,985. This comprised 4.37% of the total portfolio. The net change in shares for this position over the two quarters is 70,114. About Company: Intel Corporation designs, manufactures, and sells computer components and related products. The Company’s major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory products, graphics products, network and communications products, systems management software, conferencing products, and digital imaging products.
  • Bristol-Myers Squibb Company (NYSE:BMY): On 06/30/2011 reported holding 15,446,395 shares with a market value of $447,327,585. This comprised 2.54% of the total portfolio. On 09/30/2011 reported holding 15,943,195 shares with a market value of $500,297,446. This comprised 3.2% of the total portfolio. The net change in shares for this position over the two quarters is 496,800. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Telefonica S.a. (NYSE:TEF): On 06/30/2011 reported holding 0 shares. On 09/30/2011 reported holding 24,120,558 shares with a market value of $461,185,089. This comprised 2.95% of the total portfolio. The net change in shares for this position over the two quarters is 24,120,558. About Company: Telefonica S.A. provides telecommunications services mainly to countries in Europe and Latin America. The Company offers fixed-line and mobile telephone, Internet, and data transmission services to residential and corporate customers.
  • Microsoft Corporation (NASDAQ:MSFT): On 06/30/2011 reported holding 9,929,585 shares with a market value of $258,169,210. This comprised 1.47% of the total portfolio. On 09/30/2011 reported holding 14,942,186 shares with a market value of $371,911,000. This comprised 2.38% of the total portfolio. The net change in shares for this position over the two quarters is 5,012,601. About Company: Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
  • Valeant Pharmaceuticals International (NYSE:VRX): On 06/30/2011 reported holding 9,494,968 shares with a market value of $493,358,529. This comprised 2.8% of the total portfolio. On 09/30/2011 reported holding 9,252,751 shares with a market value of $343,462,107. This comprised 2.2% of the total portfolio. The net change in shares for this position over the two quarters is -242,217. About Company: Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders; and distributes generic and branded generic drugs in Latin America and Eastern Europe.
  • Ppg Industries Inc. (NYSE:PPG): On 06/30/2011 reported holding 4,528 shares with a market value of $411,097. This comprised 0% of the total portfolio. On 09/30/2011 reported holding 3,251,966 shares with a market value of $229,783,929. This comprised 1.47% of the total portfolio. The net change in shares for this position over the two quarters is 3,247,438. About Company: PPG Industries, Inc. supplies products for the manufacturing, construction, automotive, chemical processing, and other industries worldwide. The Company makes protective and decorative coatings, flat glass, fabricated glass products, continuous-strand fiber glass products, and industrial and specialty chemicals.
  • Royal Dutch Shell Plc (RDS-A): On 06/30/2011 reported holding 0 shares. On 09/30/2011 reported holding 3,432,818 shares with a market value of $211,186,965. This comprised 1.35% of the total portfolio. The net change in shares for this position over the two quarters is 3,432,818.
  • Oracle Corp. (NASDAQ:ORCL): On 06/30/2011 reported holding 7,231,483 shares with a market value of $237,988,104. This comprised 1.35% of the total portfolio. On 09/30/2011 reported holding 7,144,630 shares with a market value of $205,336,665. This comprised 1.31% of the total portfolio. The net change in shares for this position over the two quarters is -86,853. About Company: Oracle Corporation supplies software for enterprise information management. The Company offers databases and relational servers, application development and decision support tools, and enterprise business applications. Oracle’s software runs on network computers, personal digital assistants, set-top devices, PCs, workstations, minicomputers, mainframes, and massively parallel computers.
  • Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): On 06/30/2011 reported holding 4,476,987 shares with a market value of $232,758,562. This comprised 1.32% of the total portfolio. On 09/30/2011 reported holding 4,405,329 shares with a market value of $195,860,923. This comprised 1.25% of the total portfolio. The net change in shares for this position over the two quarters is -71,658. About Company: Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases.

(Note: Data regarding Loomis Sayles’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>